Search results
AbbVie’s RINVOQ now indicated for paediatric arthritis in US
Pharmaceutical Technology via Yahoo Finance· 1 day agoAbbVie has announced that its RINVOQ (upadacitinib) is now indicated for treating polyarticular...
AbbVie Psoriatic Arthritis Drug Shows Long-term Effect On Skin, Joint Symptoms
Benzinga via Yahoo Finance· 2 years agoAbbVie Inc (NASDAQ: ABBV) announced new, long-term data analyses of KEEPsAKE 1 and 2, Phase 3 trials...
MoonLake Jumps After Arthritis Drug Tops AbbVie Blockbuster Humira In A Key Test
Investor's Business Daily· 3 months agoBiotech stock MoonLake Immunotherapeutics rose Monday after the company said its experimental...
Can AbbVie's (ABBV) New Drugs Make up for Lost Humira Sales?
Zacks via Yahoo Finance· 2 years agoAbbVie's (ABBV) new drugs, Skyrizi and Rinvoq, are faring well, bolstered by approval in new...
Merck and AbbVie Are Facing Big Patent Cliffs, But Here's Why Both Are Still Buys
Motley Fool· 11 months agoDrug companies Merck (NYSE: MRK) and AbbVie (NYSE: ABBV) have been two of the best pharmaceutical...
AbbVie (ABBV) Provides Clinical Updates on Inflammatory Drugs
Zacks via Yahoo Finance· 1 year agoAbbVie ABBV announced multiple clinical updates pertaining to clinical studies evaluating its...
AbbVie (ABBV) Gets CHMP Nod for Skyrizi in a Third Indication
Zacks via Yahoo Finance· 2 years agoThe CHMP recommends authorizing AbbVie's (SNY) Skyrizi as a treatment for Crohn's disease. The drug...
AbbVie (ABBV) Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU
Zacks via Yahoo Finance· 3 days agoAbbVie (ABBV) announces that the EMA's CHMP issued a positive opinion on its regulatory filing...
Here's How Much a $1000 Investment in AbbVie Made 10 Years Ago Would Be Worth Today
Zacks via Yahoo Finance· 5 months agoHow much a stock's price changes over time is important for most investors, since price performance...
AbbVie's (ABBV) Rinvoq Meets Key Goal in Phase II Vitiligo Study
Zacks via Yahoo Finance· 8 months agoAbbVie ABBV announced positive results from its mid-stage study evaluating Rinvoq (upadacitinib) in...